Eterna Therapeutics
Price & Volume
Stats
See moreOpen | $2.06 |
Previous Close | $2.21 |
Day Range | $2.05-$2.06 |
52W Range | $2.12-$48 |
Market Cap | $3.6M |
Shares Short | 19,725 |
Financials
See moreRevenue (12 Mos) | $1,000 |
Revenue Growth (YoY) | -94.1% |
Gross Profit (12 Mos) | $1,000 |
Diluted EPS | -$13.63 |
News
See moreYahoo Finance • 3 months ago
Three Biotechs Deliver Catalysts to Watch
Yahoo Finance • 3 months ago
PayPal jumps on reported takeover bid, Aehr Test soars
Yahoo Finance • 4 months ago
Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study
Yahoo Finance • 5 months ago
Ernexa Reports 100% Survival And Complete Tumor Clearance In Ovarian Cancer Models; Stock Up
About
CEO | Mr. Sanjeev Luther |
Address | 1035 Cambridge Street, Cambridge, MA, United States, 02141 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |